GSK Recalls Around 600,000 Ventolin Asthma Inhalers In The US GlaxoSmithKline voluntarily recalled over 593,000 inhalers due to a defect in its packaging, which caused suspected propellant leakage. The company confirmed that this issue was not a direct threat to patients inhaling the product. by Anu Passary
Xi Jinping Warns Against Chip Restrictions During Talks with Dutch PM Rutte: 'No Force Can Stop China's Progress'
Researchers Achieve Record Data Transmission Speed, 4.5 Million Times Faster Than Average Home Broadband